Improving drug development for neurological diseases
VALIDATION OF BIOANALYTICAL ASSAYS AND IND- ENABLING GLP PD/PK TOXICOLOGY STUDIES
This study is helping people who create new medicines for neurological diseases by providing them with the support and tools they need to move their treatments closer to being tested in people, which could lead to better options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Battelle Centers/pub Hlth Res & Evaluatn NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-11212584 on NIH RePORTER |
What this research studies
This research focuses on providing essential services and expertise to developers of therapeutics aimed at treating neurological diseases. It aims to support these developers in advancing their candidate products through the necessary stages of development, including bioanalytical assays and toxicology studies. By facilitating the transition to phase I clinical trials, the project enhances the chances of successful drug development for patients with neurological disorders. The approach combines industry-style methodologies with NIH funding to optimize therapeutic candidates.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with neurological disorders who may benefit from new therapeutic options being developed.
Not a fit: Patients with conditions unrelated to neurological diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from neurological diseases.
How similar studies have performed: Other research initiatives have successfully utilized similar approaches to advance drug development for neurological conditions, indicating a promising potential for this project.
Where this research is happening
Columbus, United States
- Battelle Centers/pub Hlth Res & Evaluatn — Columbus, United States (Active)
Researchers
- Principal investigator: Gridley, James — Battelle Centers/pub Hlth Res & Evaluatn
- Study coordinator: Gridley, James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.